AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
Dr. Michael Dickinson discusses the potential of bi-specific T cell engaging antibodies in the clinical management of lymphoma, including his experience with clinical trials and the future of immunotherapies.